Armatus Bio Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $3M

  • Investors
  • 8

Armatus Bio General Information

Description

Developer of vectorized therapeutics designed to target and silence specific genes. The company uses genetic science and bioengineering to deliver therapies specifically targeting affected tissues in genetic neuromuscular diseases, enabling medical professionals to offer effective treatment options for patients with rare conditions.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1275 Kinnear Road
  • Columbus, OH 43212
  • United States
+1 (614)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1275 Kinnear Road
  • Columbus, OH 43212
  • United States
+1 (614)

Armatus Bio Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Armatus Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 06-May-2025 $3M Completed Pre-Clinical Trials
1. Seed Round 14-Nov-2023 Completed Pre-Clinical Trials
To view Armatus Bio’s complete valuation and funding history, request access »

Armatus Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed
To view Armatus Bio’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Armatus Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of vectorized therapeutics designed to target and silence specific genes. The company uses genetic science and
Drug Discovery
Columbus, OH
7 As of 2025

Cambridge, MA
 

Waltham, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Armatus Bio Competitors (3)

One of Armatus Bio’s 3 competitors is Sarepta Therapeutics, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sarepta Therapeutics Formerly VC-backed Cambridge, MA
Dyne Therapeutics Formerly VC-backed Waltham, MA
Avidity Biosciences Formerly VC-backed San Diego, CA
You’re viewing 3 of 3 competitors. Get the full list »

Armatus Bio Patents

Armatus Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026097050-A1 Products and methods for measuring the potency of a silencing gene therapy Pending 04-Nov-2024
AU-2025252320-A1 Products and methods for treating diseases or disorders associated with dux4 overexpression Pending 03-Apr-2024
WO-2025212838-A1 Products and methods for treating diseases or disorders associated with dux4 overexpression Pending 03-Apr-2024 C12N15/113

Armatus Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Armatus Bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angel Physicians Fund Angel Group Minority
CincyTech Venture Capital Minority
CMT Research Foundation Not-For-Profit Venture Capital Minority
Jumpstart Ventures Venture Capital Minority
R1 Capital (Columbus) Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Armatus Bio FAQs

  • When was Armatus Bio founded?

    Armatus Bio was founded in 2020.

  • Where is Armatus Bio headquartered?

    Armatus Bio is headquartered in Columbus, OH.

  • What is the size of Armatus Bio?

    Armatus Bio has 7 total employees.

  • What industry is Armatus Bio in?

    Armatus Bio’s primary industry is Drug Discovery.

  • Is Armatus Bio a private or public company?

    Armatus Bio is a Private company.

  • What is Armatus Bio’s current revenue?

    The current revenue for Armatus Bio is .

  • How much funding has Armatus Bio raised over time?

    Armatus Bio has raised $14.8M.

  • Who are Armatus Bio’s investors?

    Angel Physicians Fund, CincyTech, CMT Research Foundation, Jumpstart Ventures, and R1 Capital (Columbus) are 5 of 8 investors who have invested in Armatus Bio.

  • Who are Armatus Bio’s competitors?

    Sarepta Therapeutics, Dyne Therapeutics, and Avidity Biosciences are competitors of Armatus Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process